Journal of Herbmed Pharmacology,
Journal Year:
2024,
Volume and Issue:
14(1), P. 29 - 42
Published: Dec. 25, 2024
Introduction:
Cannabis
sativa
threshing
residue
is
the
plant
material
left
after
extracting
resinous
trichomes
from
dried
female
plant.
This
study
examines
phytochemical
properties
of
C.
and
screens
its
vasorelaxant,
antimicrobial,
immunomodulatory
activities.
Methods:
The
was
extracted
sequentially
using
hexane,
dichloromethane,
ethyl
acetate,
ethanol.
four
fractions
were
analyzed
by
gas
chromatography-mass
spectrometry.
Phenolic
flavonoid
contents
estimated
Folin-Ciocalteu
reagent
aluminum
chloride
colorimetric
methods.
2,2-diphenyl-1-picrylhydrazyl
(DPPH)
assay
determined
in
vitro
antioxidant
activity.
vasorelaxant
effect
explored
rat
mesenteric
arterial
beds
(MABs).
Antimicrobial
studies
on
Salmonella
enterica,
Escherichia
coli,
Staphylococcus
aureus,
Bacillus
cereus
conducted
microdilution
tests.
Immunomodulatory
activity
cell
proliferation,
antibody
production,
complement
Results:
Phytochemical
analysis
revealed
many
volatile
bioactive
compounds,
including
terpenes
like
phytol
squalene
cannabinoids
delta-9-tetrahydrocannabinol
cannabidiol
(CBD).
had
significant
polyphenol
content.
They
dose-dependently
dilated
MAB
demonstrated
varying
DPPH
free
radical
scavenging
showed
an
immunosuppressive
proliferation
biological
functions.
bacterial
strains
studied
sensitive
to
but
with
different
degrees.
Conclusion:
diverse
pharmacological
potential,
suggesting
suitability
for
developing
cannabis-based
medications
targeting
hypertension-related
damage,
radicals,
bacteria,
expanding
potential
applications
beyond
inflammation-related
conditions
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(2), P. 148 - 148
Published: Jan. 23, 2025
Background/Objectives:
Current
inflammatory
bowel
disease
(IBD)
treatments
focus
on
symptomatic
relief,
highlighting
the
need
for
innovative
approaches.
Dysregulation
of
cannabinoid
1
(CB1)
receptor,
part
endocannabinoid
system,
is
linked
to
colitis.
While
tetrahydrocannabinol
(THC)
alleviates
colitis
via
CB1
activation,
its
psychotropic
effects
limit
clinical
use.
ZCZ011,
a
CB1R
allosteric
modulator,
and
cannabidiol
(CBD),
non-psychoactive
cannabinoid,
offer
alternatives.
This
study
investigated
combining
sub-therapeutic
THC
doses
with
ZCZ011
or
CBD
in
murine
model
dextran
sodium
sulphate
(DSS)-induced
Methods:
Acute
was
induced
4%
DSS
7
days,
followed
by
3
days
water.
Chronic
modelled
over
24
alternating
concentrations.
The
combination
2.5
mg/kg
20
10
evaluated.
Key
markers
were
assessed
determine
efficacy
safety,
including
activity
index
(DAI),
inflammation,
cytokine
levels,
GLP-1,
organ
health.
Results:
DSS-induced
resulted
increased
DAI
scores,
cytokines,
inflammation
dysregulation
GLP-1
ammonia.
at
significantly
improved
but
ineffective
5
mg/kg.
alone
showed
transient
effects.
However,
either
alleviated
markers,
restored
colon
integrity
reestablished
homeostasis.
also
maintained
favourable
haematological
biochemical
profiles,
notable
reduction
colitis-induced
elevated
ammonia
levels.
Conclusions:
demonstrates
synergistic
potential
low-dose
combined
as
novel,
effective
safer
therapeutic
strategy
ulcerative
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(7), P. 1390 - 1390
Published: July 6, 2023
Cannabis
leaves
contain
a
diverse
range
of
antioxidants,
including
cannabinoids,
flavonoids,
and
phenolic
compounds,
which
offer
significant
health
benefits.
Utilising
cannabis
as
source
antioxidants
presents
cost-effective
approach
because
they
are
typically
discarded
during
the
cultivation
plants
for
their
seeds
or
fibres.
Therefore,
this
presented
study
aimed
to
assess
antioxidant
activity
selected
hemp
cultivars,
such
Białobrzeska,
Tygra,
Henola,
based
on
results
obtained
with
2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic
acid,
ferric
reducing
power,
cupric
capacity,
2,2-Diphenyl-1-picrylhydrazyl
assays.
The
cannabinoid
profile
was
analysed
contents
cannabidiol
(CBD),
cannabigerol
(CBG),
Δ9-tetrahydrocannabinol
(Δ9-THC),
cannabichromene
(CBC),
determined
chromatographic
following
variables
were
tested:
impact
various
extractants
(methanol,
ethanol,
isopropanol),
mixtures
(50:50,
v/v,
well
extraction
methods
(maceration
ultra-sound-assisted
extraction)
in
obtaining
extracts
characterised
by
different
profiles.
revealed
that
selection
extractant
conditions
significantly
influenced
active
compounds'
efficiency
activity.
Among
tested
conditions,
ultrasound-assisted
using
methanol
yielded
highest
profile:
CBD
=
184.51
±
5.61;
CBG
6.10
0.21;
Δ9-THC
0.51
0.01;
CBC
0.71
0.01
μg/g
potential
Białobrzeska
leaf
extracts.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(9), P. 4744 - 4744
Published: April 26, 2024
Cannabidiol
(CBD)
is
a
non-psychoactive
compound
derived
from
Cannabis
sativa.
It
has
demonstrated
promising
effects
in
combating
inflammation
and
holds
potential
as
treatment
for
the
progression
of
chronic
inflammation.
However,
clinical
application
CBD
limited
due
to
its
poor
solubility
bioavailability.
This
study
introduces
an
effective
method
preparing
CBD-loaded
solid
lipid
nanoparticles
(CBD-SLNs)
using
combination
low-energy
hot
homogenization
ultrasonication.
We
enhanced
this
process
by
employing
statistical
optimization
with
response
surface
methodology
(RSM).
The
optimized
CBD-SLN
formulation
utilizes
glyceryl
monostearate
primary
component
nanocarrier.
screened
tool
managing
Stable,
uniformly
dispersed
spherical
size
123
nm,
charge
−32.1
mV,
encapsulation
efficiency
95.16%,
drug
loading
2.36%
were
obtained.
CBD-SLNs
exhibited
sustained
release
properties,
ensuring
prolonged
controlled
delivery,
which
could
potentially
amplify
therapeutic
effects.
Additionally,
we
observed
that
significantly
reduced
both
reactive
oxygen
nitrogen
species
proinflammatory
cytokines
chondrocyte
macrophage
cell
lines,
these
inhibitory
being
more
pronounced
than
those
free
CBD.
In
conclusion,
superiority
over
CBD,
highlighting
delivery
system
Background
In
this
study
we
investigated
in
detail
the
role
of
cannabidiol
(CBD),
Beta-caryophyllene
(BC),
or
their
combinations
diabetic
peripheral
neuropathy
(DN).
The
key
factors
that
contribute
to
DN
include
mitochondrial
dysfunction,
inflammation,
and
oxidative
stress.
Methods
Briefly,
Streptozotocin
(STZ)
(55
mg/kg)
was
injected
intraperitoneally
induce
Sprague
Dawley
rats
performed
procedures
including
Randall
Sellito
Calipers,
Von
Frey
Aesthesiometer,
hot
plate,
cold
plate
methods
determine
mechanical
thermal
hyperalgesia
vivo.
blood
flow
nerves
assessed
by
using
Laser
Doppler
device.
Schwann
cells
were
exposed
high
glucose
(HG)
at
a
dose
30
mM
hyperglycemia
DCFDA,
JC1
&
Mitosox
staining
done
membrane
potential,
reactive
oxygen
species
superoxides
in-vitro.
administered
i.p
with
BC
(30mg/kg),
CBD
(15mg/kg),
combination
while
treated
3.65
µM
CBD,
75
BC,
assess
amelioration.
Results
Our
results
revealed
exposure
diminished
HG-induced
cells,
part,
through
reducing
superoxides.
Further,
treatment
in-vivo
could
prevent
deterioration
quality
control
system
promoting
autophagy
biogenesis
improving
flow.
treatments
also
reduced
pain
hypersensitivity
allodynia
increased
antioxidant
anti-inflammatory
action
rats.
These
vivo
effects
attributed
significant
upregulation
AMPK,
SIRT3,
Nrf2,
PINK1,
PARKIN,
LC3B,
Beclin1
TFAM
functions
downregulation
NLRP3
inflammasome,
NFκB,
COX2
p62
activity
noted
as
determined
western
blotting.
Conclusion
present
studies
demonstrated
STZ
HG
induced
nitrosative
stress
play
crucial
pathogenesis
neuropathy.
We
find,
for
first
time,
ameliorate
via
modulating
system.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(7), P. 1442 - 1442
Published: June 28, 2024
In
this
study,
we
investigated
in
detail
the
role
of
cannabidiol
(CBD),
beta-caryophyllene
(BC),
or
their
combinations
diabetic
peripheral
neuropathy
(DN).
The
key
factors
that
contribute
to
DN
include
mitochondrial
dysfunction,
inflammation,
and
oxidative
stress.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(12), P. 2664 - 2664
Published: June 7, 2023
There
is
a
lack
of
research
on
the
effects
cannabidiol
(CBD)
health-related
fitness,
physical
activity,
cognitive
health,
psychological
wellbeing,
and
concentrations
C-reactive
protein
(CRP)
in
healthy
individuals.
CBD
has
potential
anti-inflammatory
neuroprotective
effects.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 2853 - 2853
Published: March 21, 2025
Periodontitis
is
unanimously
accepted
to
be
the
sixth
complication
of
diabetes
mellitus
(DM),
while
inverse
relationship
causality
still
deciphered.
Among
proposed
mechanisms
gut
dysbiosis,
which
responsible
for
systemic
release
proinflammatory
mediators.
In
this
process,
Gram-negative
bacteria
from
oral
cavity
enter
general
circulation,
leading
emergence
bi-hormonal
beta-pancreatic
cells
that
lack
ability
secrete
insulin.
Additionally,
epigenetic
and
adaptive
in
affected
may
play
a
role
reducing
inflammation.
The
reactive
oxygen
species,
cytokines,
adipokines,
such
as
interleukins,
tumor
necrosis
factor
alpha,
leptin,
prostaglandin
E2,
C-reactive
protein,
or
matrix
metalloproteinases,
determine
changes,
methylation
DNA
nucleotides
changes
activity
histone
acetylases/deacetylases.
management
periodontitis
involves
targeting
inflammation,
its
potential
connection
modulation
observed
other
chronic
conditions
help
explain
preventing
DM
patients.
This
review
focuses
on
key
might
contribute
development,
explores
novel
multi-drug
therapies
could
prevent
these
effects.